English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The COVID19 pandemic seems to have affected the financial results of the companies operating in Central and Eastern Europe. This paper has as a main goal to analyse the impact of COVID-19 crisis over companies which operate in the pharmaceutical sector.  Since two of the authors developed an article in 2018 concentrated on the Early warning indicators and their impact over the medical companies registered in the Bucharest Stock Exchange, the current article analysis the same indicators but extends them at the level of four countries: Romania, Croatia, Slovenia and Hungary. Within the paper the authors will compare the evolution of several financial indicators: liquidity, financial leverage, solvency, annual return, ROE, ROA, so on in context of COVID-19. The main reason for the selection of medical and pharmaceutical sector is constituted by the discussions that these companies benefit from the effects of COVID19.

THE IMPACT OF THE COVID-19 PANDEMICS OVER THE FINANCIAL PERFORMANCE AT THE LEVEL OF THE MAIN PHARMACEUTICAL OPERATING IN CENTRAL AND EASTERN EUROPE